PROactive Evaluation of Function to Avoid CardioToxicity

Clinical trial NCT03862131 · TERMINATED

Trial details

NCT number: NCT03862131
Sponsor: Washington University School of Medicine
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Cardiotoxicity Breast Cancer Lymphoma Sarcoma Leukemia Myeloma Lung Cancer

Start date: 2019-03-13
Primary completion: 2024-06-14
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.